Phase II study of pharmacogenetic-tailored therapy in elderly colorectal cancer patients-Reference-Cited by-同舟云学术

Phase II study of pharmacogenetic-tailored therapy in elderly colorectal cancer patients

Published:2012-01 Issue:1 Volume:44 Page:74-79
ISSN:1590-8658
Container-title:Digestive and Liver Disease
language:en
Short-container-title:Digestive and Liver Disease

Author:

Scartozzi Mario,Loretelli Cristian,Berardi Rossana,Pierantoni Chiara,Silva Rosa Rita,Mari Davide,Giampieri Riccardo,Faloppi Luca,Pistelli Mirco,Maccaroni Elena,Bittoni Alessandro,Del Prete Michela,Galizia Eva,Cascinu Stefano

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference26 articles.

1. Epidemiology and aging;Furner,1997

2. Relationship between age at diagnosis and treatment received by cancer patients;Mor;J Am Geriatric Soc,1985

3. Population based variation in the use of chemotherapy for colorectal cancer in the elderly;Sundararajan,1999

4. Elderly patients with advanced colorectal cancer: tolerability and activity of chemotherapy;Berardi;Tumori,2005

5. Pharmacogenetic profiling in patients with advanced colorectal cancer treated with first-line FOLFOX-4 chemotherapy;Ruzzo;J Clin Oncol,2007

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular Tests for the Choice of Cancer Therapy;Current Pharmaceutical Design;2017-12-21

2. Impact of excision repair cross-complementing gene 1 (ERCC1) on the outcomes of patients with advanced gastric cancer: correlative study in Japan Clinical Oncology Group Trial JCOG9912;Annals of Oncology;2013-10

3. A Review of Pharmacogenetics of Adverse Drug Reactions in Elderly People;Drug Safety;2012-01